Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure

Journal of Cardiology

Volumn 46, Issue 1, 2005, Pages 9-15

  Niizeki, Takeshi ^a   Takeishi, Yasuchika ^a   Arimoto, Takanori ^a   Okuyama, Hidenobu ^a   Takabatake, Noriaki ^a   Tachibana, Hidetada ^a   Nozaki, Naoki ^a   Hirono, Osamu ^a   Tsunoda, Yuichi ^a   Miyashita, Takehiko ^a   Fukui, Akio ^a   Takahashi, Hiroki ^a   Koyama, Yo ^a   Shishido, Tetsuro ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Elderly; Heart failure; Prognosis (heart type fatty acid binding protein)

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CAUSE OF DEATH; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HEART DEATH; HEART FAILURE; HEART MUSCLE INJURY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARRIER PROTEINS; CHRONIC DISEASE; FATTY ACID-BINDING PROTEINS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; SEVERITY OF ILLNESS INDEX;

EID: 23344442387     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ: Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study. Lancet 2001; 358: 439-444
2. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM: Congestive heart failure in the community: A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-2289
3. Kannel WB, Belanger AJ: Epidemiology of heart failure. Am Heart J 1991; 121: 951-957
4. Cicoira M, Davos CH, Florea V, Shamim W, Doehner W, Coats AJ, Anker SD: Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old. Am Heart J 2001; 142: 174-180
5. Priebe HJ: The aged cardiovascular risk patient. Br J Anaesth 2000; 85: 763-778
6. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE: The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J 2001; 22: 1318-1327
7. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115
8. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ: Evidence of improving prognosis in heart failure: Trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation 2000; 102: 1126-1131
9. Glatz JFC, Paulussen RJA, Veerkamp JH: Fatty acid-binding proteins from heart. Chem Phys Lipids 1985; 38: 115-129
10. Schaap FG, van der Vusse GJ, Glatz JFC: Fatty acid-binding proteins in the heart. Mol Cell Biochem 1998; 180: 43-51
11. Panteghini M: Standardization activities of markers of cardiac damage: The need of a comprehensive approach. Eur Heart J 1998; 19(Suppl N): N8-N11
12. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y: Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002; 113: 717-722
13. Arimoto T, Takeishi Y, Shiga R, Fukui A, Tachibana H, Nozaki N, Hirono O, Nitobe J, Miyamoto T, Hoit BD, Kubota I: Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 2005; 11: 56-60
14. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, Dohi Y: Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003; 89: 1303-1307
15. van Veldhuisen DJ, Boomsma F, de Kam PJ, Man in't Veld AJ, Crijns HJ, Hampon JR, Lie KI: Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. Eur Heart J 1998; 19: 753-760
16. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M: High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587-1593
17. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL: Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997; 36: 246-255
18. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HP). Lancet 1999; 353: 2001-2007
19. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999; 353: 9-13